Skip to main content
رجوع
ICLR logo

ICON Public Limited Company

جودة البيانات: 100%
ICLR
NASDAQ Healthcare Medical - Diagnostics & Research
KWD 100.35
▲ KWD 0.65 (0.65%)
القيمة السوقية: 7.66B
نطاق اليوم
KWD 99.88 KWD 103.35
نطاق 52 أسبوعًا
KWD 66.57 KWD 211.00
حجم التداول
802,780
متوسط 50 يوم / 200 يوم
KWD 136.39 / KWD 161.56
الإغلاق السابق
KWD 99.70

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 9.7 0.4
P/B 0.8 2.9
ROE % 8.4 3.8
Net Margin % 9.6 3.9
Rev Growth 5Y % 31.2 10.0
D/E 0.4 0.2

السعر المستهدف للمحللين

Hold
KWD 157.440 +56.9%
Low: KWD 100.000 High: KWD 222.000
مكرر الربحية المستقبلي
8.0
ربحية السهم المستقبلية
KWD 12.527
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
8 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 15.693
KWD 15.060 – KWD 16.002
 8.9 B 1
FY2028 KWD 14.979
KWD 10.436 – KWD 18.431
 8.7 B 5
FY2027 KWD 13.572
KWD 9.694 – KWD 16.940
 8.3 B 7

النقاط الرئيسية

Revenue grew 31.17% annually over 5 years — strong growth
Earnings grew 29.26% over the past year
Debt/Equity of 0.38 — conservative balance sheet
Generating 1.12B in free cash flow
P/E of 9.68 — trading at a low valuation
PEG of 0.76 suggests growth is underpriced

النمو

Revenue Growth (5Y)
31.17%
Revenue (1Y)1.99%
Earnings (1Y)29.26%
FCF Growth (3Y)62.97%

الجودة

Return on Equity
8.44%
ROIC6.27%
Net Margin9.56%
Op. Margin13.26%

الأمان

Debt / Equity
0.38
Current Ratio1.26
Interest Coverage4.63

التقييم

P/E Ratio
9.68
P/B Ratio0.80
EV/EBITDA9.77
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.99% Revenue Growth (3Y) 3.43%
Earnings Growth (1Y) 29.26% Earnings Growth (3Y) 25.15%
Revenue Growth (5Y) 31.17% Earnings Growth (5Y) 24.65%
Profitability
Revenue (TTM) 8.28B Net Income (TTM) 791.47M
ROE 8.44% ROA 4.69%
Gross Margin 29.42% Operating Margin 13.26%
Net Margin 9.56% Free Cash Flow (TTM) 1.12B
ROIC 6.27% FCF Growth (3Y) 62.97%
Safety
Debt / Equity 0.38 Current Ratio 1.26
Interest Coverage 4.63 Dividend Yield 0.00%
Valuation
P/E Ratio 9.68 P/B Ratio 0.80
P/S Ratio 0.93 PEG Ratio 0.76
EV/EBITDA 9.77 Dividend Yield 0.00%
Market Cap 7.66B Enterprise Value 10.73B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 8.28B 8.12B 7.74B 5.48B 2.80B
Net Income 791.47M 612.34M 505.30M 153.19M 327.81M
EPS (Diluted) 9.53 7.40 6.13 2.25 6.24
Gross Profit 2.44B 2.40B 2.21B 1.51B 808.03M
Operating Income 1.10B 956.15M 795.24M 378.53M 391.50M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 16.88B 16.99B 17.19B 17.39B 3.44B
Total Liabilities 7.35B 7.75B 8.69B 9.32B 1.59B
Shareholders' Equity 9.52B 9.24B 8.50B 8.07B 1.85B
Total Debt 3.60B 3.94B 4.83B 5.65B 433.61M
Cash & Equivalents 538.79M 378.10M 288.77M 752.21M 840.31M
Current Assets 3.53B 3.41B 3.23B 2.94B 2.10B
Current Liabilities 2.80B 2.83B 2.69B 2.48B 1.12B

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#491 of 820
37
Value Defensive Investing (Benjamin Graham)
#310 of 708
32

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026